XPO1 and B-cell chronic lymphocytic leukemia: CLL patients with XPO1 E571 mutations had poor prognosis and harboured altered IFNγ, granzyme B and CD28 expression, which may contribute to the overall immune dysfunction seen in CLL patients [40, 43].